Pulpotomy as a Treatment of Irreversible Pulpitis
Pulpotomy as a Permanent Treatment of Irreversible Pulpitis on Mature Molar Teeth - a Pilot Study
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
The procedure currently recommended for the treatment of irreversible pulpitis is the endodontic treatment, i.e. the complete elimination of the pulp, disinfection and obturation of the whole root canal system. The emergency procedure consists of a pulpotomy, followed at an ulterior appointment by the root canal treatment. The purpose of the present pilot study is to evaluate the feasibility of performing the pulpotomy as a permanent treatment in mature molars. If hemostasis can be achieved after removing the coronal part of the pulp, a tricalcium silicate cement will be directly applied on the remaining pulp at the root canal entrances. A short-term follow-up will be performed at one week by evaluating the pain relief of the patient. Long-term success will then be evaluated every year by verifying the absence of periapical radiolucency on the x-ray as well as the absence of clinical symptoms and signs. A standard root canal procedure will serve as control. During the pulpotomy treatment, blood sample with microcapillary will be performed. We will analyze a ratio of pro-inflammatory and anti-inflammatory cytokines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2016
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 30, 2016
CompletedFirst Posted
Study publicly available on registry
September 30, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedMarch 11, 2021
March 1, 2021
5.5 years
May 30, 2016
March 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the success rate (%) at 1 year
to evaluate the treatment success defined as the absence of clinical symptoms (pain, sinus tract..) and the absence of radiological symptoms (periapical radiolucency), in order to point the non-inferiority of the pulpotomy compared with the conventional treatment
Follow up at 1 year for all patients included in the study
Secondary Outcomes (1)
Evaluation of the correlation between pro/anti-inflammatory cytokines and the success of pulpotomy
Follow up at 1 year for all patients included in the study
Other Outcomes (1)
Evaluation of the success rate (%) up to 4 years
Follow up at 4 years for all patients included in the test group
Study Arms (2)
Endodontic treatment
ACTIVE COMPARATORThe patient will benefit from a conventional treatment : a root canal treatment. The root canal treatment consists of removing the pulp tissue from all the canals, disinfecting the root canal system with sodium hypochlorite and filling the root with a root canal sealer and gutta percha.
Pulpotomy
EXPERIMENTALThe patient will benefit from an experimental treatment : a pulpotomy. The pulpotomy aims at removing the coronal part of the pulp (the pulp present in the pulp chamber) and filling the pulp chamber with a bioactive material.
Interventions
Eligibility Criteria
You may qualify if:
- Good general health
- Not pregnant women
- At least one permanent molar in irreversible pulpitis
- Adult patient
- Mentally competent
You may not qualify if:
- Periapical radiolucency
- Periodontical probing
- Root fracture
- Sinus tract
- Swelling or mobility
- External or/and internal resorption
- Open apicies
- A non restorable tooth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Julian G Leprince, Professor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2016
First Posted
September 30, 2016
Study Start
April 1, 2016
Primary Completion
October 1, 2021
Study Completion
June 1, 2024
Last Updated
March 11, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share